Clinical Trial Update: Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effect of famotidine on the pharmacokinetics of atazanavir when coadministered in people with HIV; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Pepcid (famotidine)
• REYATAZ (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV | Phase 4 | Status: COMPLETED | Results posted: 2012-08-28